InvestorsHub Logo

flipper44

03/03/16 8:35 PM

#55948 RE: Doc logic #55944

Interesting. That seems like one possible scenario/narrative.

john1045

03/03/16 9:14 PM

#55951 RE: Doc logic #55944

Doc....totally agree on where a significant investment of funds has gone to manufacturing and automation for commercialization. I also agree on label extensions for other solid tumors once approved is huge opportunity as well. I also agree with Flip on UK commitment of $ for commercial expansion of DCVax manufacturing hub for Europe as noted in Oct 2015.

antihama

03/04/16 3:35 PM

#56020 RE: Doc logic #55944

label extensions are all that are needed once approved

Doc logic, can you clarify what would that entail? I wrestle with this all the time but my current understanding is it would need a confirmatory trial for each label extension or is it more of a pharmacokinetic study in pts with that type of cancer or maybe something in between?